Status:
ACTIVE_NOT_RECRUITING
Effectiveness of Exergaming in Adittion to Conventional Treatment for Physical Therapy in People with Multiple Sclerosis
Lead Sponsor:
Universidad de Córdoba
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The present study aims to evaluate the effectiveness of two different exergaming systems in addition to conventional treatment on physical functional capacity, balance, muscle strength, spasticity in ...
Detailed Description
Multiple sclerosis is a chronic autoimmune inflammatory disease of the central nervous system, which produces demyelination and axonal damage in the brain and spinal cord. Since there is currently no ...
Eligibility Criteria
Inclusion
- (i) Diagnosis of MS in any of its types (clinically isolated syndrome, relapsing-remitting MS, primary progressive MS or secondary progressive MS) based on the McDonald criteria.
- (ii) Age over 18 years.
- (iii) Mini-Mental State Examination score \> 19 points.
- (iv) Score on the Expanded Disability Status Scale (EDSS) under 7.0 points.
Exclusion
- (i) Diagnosis of another disease that affects balance and/or coordination.
- (ii) Exacerbation or steroid treatment in the 30 days prior to inclusion in the study.
- (iii) Presence of visual deficits.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06196866
Start Date
September 1 2023
End Date
June 1 2025
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cordoba
Córdoba, Cordoba, Spain, 14071